NanoVibronix (NASDAQ:NAOV) stock is climbing higher on Wednesday after announcing independent results from a study of its UroShield medical device.
The study comes from the University of Southampton in the U.K. Results from that study were positive, with its conclusion noting that UroShield’s method of delivery of low-frequency ultrasound to prevent complications from catheters.
Here’s the concluding statement of that study, which is titled “Understanding the Use of the NanoVibronix® UroShield® in Preventing Catheter-Associated Infections and Blockage.”
“The positive reported outcomes and the data from these preliminary studies indicate an effect on the community structure of the microbial populations found in the urine and forming the biofilm. This indicates potential for developing a healthy urinary microbiome by use of low frequency ultrasound, thus avoiding longterm use of antibiotics and the risks associated with such strategies.”
What This Means for NAOV Stock
Having this study back up NanoVibronix’s UroShield is a major win for NAOV stock. It also brought additional attention to the company’s shares today. As such, heavy trading is taking place. That has more than 40 million shares changing hands as of this writing. For comparison, the company’s daily average trading volume is around 6,000 shares.
NAOV stock is up 153.4% as of Wednesday morning but is still down 19.1% since the start of the year.
Traders seeking out even more of the most recent stock market news today will want to keep reading!
We have all of the hottest stock market news that’s worth reading about on Wednesday! Among that is what’s moving shares of Nvidia (NASDAQ:NVDA), Sunrun (NASDAQ:RUN), and ChargePoint (NYSE:CHPT) stock today. You can catch up on all of these matters by checking out the links below!
More Stock Market News for Wednesday
- NVDA Stock Alert: Nvidia Closes at New Record High
- Sunrun (RUN) Stock Pops 3% on Analyst Upgrade
- ChargePoint (CHPT) Stock Just Got a Nod From JPMorgan
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risk.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
